Patent Assignment
Reel/Frame 047611/0041
Assignment of Assignor's Interest
Recorded: 2018-11-28
Pages: 6
Assignor
IMMUNE PHARMACEUTICALS LTD.
Executed: 2018-11-28
Assignee
IMMUNE PHARMACEUTICALS, INC.
1 BRIDGE PLAZA N STE 270, FORT LEE, NEW JERSEY, 07024
Covered Properties
(3)
Use of Anti-Eotaxin Antibodies for Treating Inflammatory Bowel Disease
Application:
13/803,646 →
Publication:
US 2014/0271663
Use of Anti-Eotaxin Antibodies for Treating Inflammatory Bowel Disease
Application:
13/864,387 →
Publication:
US 2014/0271666
Use of Anti-Eotaxin Antibodies for Treating Inflammatory Bowel Disease
Application:
15/347,847 →
Publication:
US 2017/0247442
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 8, 2013
From: TEPER, DANIEL
To: IMMUNE PHARMACEUTICALS LTD.
Reel/Frame 030748/0348 →
Assignment of Assignor's Interest
Feb 5, 2017
From: TEPER, DANIEL
To: IMMUNE PHARMACEUTICALS LTD.
Reel/Frame 041174/0369 →
Security Interest
Oct 9, 2018
From: IMMUNE PHARMACEUTICALS INC.
To: DISCOVER GROWTH FUND, LLC
Reel/Frame 047107/0116 →